| Cvs Pharmacy #16633 | |
| 475 Hartford Rd, New Britain, Connecticut 06053 | |
| (860) 348-9163 |
| Name | Cvs Pharmacy #16633 |
|---|---|
| Organization Name | Connecticut Cvs Pharmacy Llc |
| Location | 475 Hartford Rd, New Britain, Connecticut 06053 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (860) 348-9163 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
New research published online today in Circulation Research found that injections of adult patients' own CD34+ stem cells reduced reports of angina episodes and improved exercise tolerance time in patients with chronic, severe refractory angina (severe chest discomfort that did not respond to other therapeutic options).
Recent findings on HIV vaccine research, some presented recently at the AIDS Vaccine 2011 conference in Bangkok, "show that the science of an AIDS vaccine is vibrant and vital," Mitchell Warren, executive director of AVAC-Global Advocacy for HIV Prevention, writes in a "Science Speaks" guest blog post.
Governments and other organizations must intensify efforts to improve the health of women and children, particularly in the developing world where the lion's share of deaths occur, says Dr. Philip Baker, an internationally renowned medical researcher in obstetrics & gynecology. Baker is the lead author on a G8 positioning paper that included consultations with 20 of the world's leading medical experts on women and children's health.
Electronic medical records could improve how care is delivered and financed, but too few doctors and hospitals use it now, Health and Human Services Secretary Kathleen Sebelius told attendees at the Cerner Health Conference in Kansas City Tuesday, the Kansas City Star reports.
AFFiRiS AG announced today significant progress in their collaboration with GlaxoSmithKline Biologicals (GSK) for the development of an active vaccination programme against Alzheimer´s disease. While the lead vaccine candidate AD02 is currently in phase II clinical testing, two additional preclinical programmes have been completed successfully. The second programme was related to alternative vaccine candidates generated by AFFiRiS´ AFFITOME® technology, including candidate AD03. Based on the promising preliminary results of this programme, GSK exercised its option for the alternative vaccine candidates which triggered a EUR 2.5 million payment to AFFiRiS. An additional EUR 1 million payment became due simultaneously for the successful completion of tests of alternative vaccine formulations.
› Verified 6 days ago
| NPI Number | 1891717492 |
| Organization Name | CONNECTICUT CVS PHARMACY LLC |
| Doing Business As | CVS PHARMACY #16633 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 475 Hartford Rd, New Britain, CT 06053 |
| Phone Number | 860-348-9163 |
News Archive
New research published online today in Circulation Research found that injections of adult patients' own CD34+ stem cells reduced reports of angina episodes and improved exercise tolerance time in patients with chronic, severe refractory angina (severe chest discomfort that did not respond to other therapeutic options).
Recent findings on HIV vaccine research, some presented recently at the AIDS Vaccine 2011 conference in Bangkok, "show that the science of an AIDS vaccine is vibrant and vital," Mitchell Warren, executive director of AVAC-Global Advocacy for HIV Prevention, writes in a "Science Speaks" guest blog post.
Governments and other organizations must intensify efforts to improve the health of women and children, particularly in the developing world where the lion's share of deaths occur, says Dr. Philip Baker, an internationally renowned medical researcher in obstetrics & gynecology. Baker is the lead author on a G8 positioning paper that included consultations with 20 of the world's leading medical experts on women and children's health.
Electronic medical records could improve how care is delivered and financed, but too few doctors and hospitals use it now, Health and Human Services Secretary Kathleen Sebelius told attendees at the Cerner Health Conference in Kansas City Tuesday, the Kansas City Star reports.
AFFiRiS AG announced today significant progress in their collaboration with GlaxoSmithKline Biologicals (GSK) for the development of an active vaccination programme against Alzheimer´s disease. While the lead vaccine candidate AD02 is currently in phase II clinical testing, two additional preclinical programmes have been completed successfully. The second programme was related to alternative vaccine candidates generated by AFFiRiS´ AFFITOME® technology, including candidate AD03. Based on the promising preliminary results of this programme, GSK exercised its option for the alternative vaccine candidates which triggered a EUR 2.5 million payment to AFFiRiS. An additional EUR 1 million payment became due simultaneously for the successful completion of tests of alternative vaccine formulations.
› Verified 6 days ago
News Archive
New research published online today in Circulation Research found that injections of adult patients' own CD34+ stem cells reduced reports of angina episodes and improved exercise tolerance time in patients with chronic, severe refractory angina (severe chest discomfort that did not respond to other therapeutic options).
Recent findings on HIV vaccine research, some presented recently at the AIDS Vaccine 2011 conference in Bangkok, "show that the science of an AIDS vaccine is vibrant and vital," Mitchell Warren, executive director of AVAC-Global Advocacy for HIV Prevention, writes in a "Science Speaks" guest blog post.
Governments and other organizations must intensify efforts to improve the health of women and children, particularly in the developing world where the lion's share of deaths occur, says Dr. Philip Baker, an internationally renowned medical researcher in obstetrics & gynecology. Baker is the lead author on a G8 positioning paper that included consultations with 20 of the world's leading medical experts on women and children's health.
Electronic medical records could improve how care is delivered and financed, but too few doctors and hospitals use it now, Health and Human Services Secretary Kathleen Sebelius told attendees at the Cerner Health Conference in Kansas City Tuesday, the Kansas City Star reports.
AFFiRiS AG announced today significant progress in their collaboration with GlaxoSmithKline Biologicals (GSK) for the development of an active vaccination programme against Alzheimer´s disease. While the lead vaccine candidate AD02 is currently in phase II clinical testing, two additional preclinical programmes have been completed successfully. The second programme was related to alternative vaccine candidates generated by AFFiRiS´ AFFITOME® technology, including candidate AD03. Based on the promising preliminary results of this programme, GSK exercised its option for the alternative vaccine candidates which triggered a EUR 2.5 million payment to AFFiRiS. An additional EUR 1 million payment became due simultaneously for the successful completion of tests of alternative vaccine formulations.
› Verified 6 days ago
Cvs Pharmacy #00294 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 177 Columbus Blvd, New Britain, Connecticut 06051 Phone: (860) 229-3757 | |
Cvs Pharmacy #00760 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 713 W Main St, New Britain, Connecticut 06053 Phone: (860) 224-3494 | |
Cvs Pharmacy #16633 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 475 Hartford Rd, New Britain, Connecticut 06053 Phone: (860) 348-9163 | |
Beacon Prescriptions Type: Durable Medical Equipment & Medical Supplies Supplier Location: 543 W Main St, New Britain, Connecticut 06053 Phone: (860) 225-6487 | |
New Britain Medical Supplies Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 74 Vine Street, New Britain, Connecticut 06052 Phone: (860) 224-9017 |